JO
Johannes Jacobus Oosthuizen
EVP, Oncology & Int?l

Johannes Jacobus Oosthuizen insider trades: Merck (MRK) stock sales

EVP, Oncology & Int?l, Merck Last trade Feb 6, 2026 24 Form 4 filings
$1.8M
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
7
Open-market trades
since 2022
2
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Johannes reports to the SEC

Open-market buys and sales

7 trades reported on SEC Form 4, newest first

DateStockTypeValue
Feb 6, 2026MRK↓ Sell$1.8M
Feb 19, 2025MRK↓ Sell$715K
Feb 2, 2024MRK↓ Sell$2.4M
Nov 9, 2023MRK↓ Sell$213K
Nov 9, 2022MRK↓ Sell$185K
Nov 7, 2022MRK↓ Sell$4.5M
Oct 28, 2022MRK↓ Sell$364K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other MRK insiders

Open-market trades in the last 12 months

About Johannes Jacobus Oosthuizen's insider trades

Johannes Jacobus Oosthuizen is EVP, Oncology & Int?l at Merck (MRK). Since Oct 28, 2022, Johannes has reported no open-market purchases and 7 sales worth $10.2M on SEC Form 4. In the last 12 months: 1 sale ($1.8M).

Their filings also include option exercises (11 filings), grants and awards (10 filings), shares withheld for taxes (9 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MRK insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.